[1]贝明龙,缪 瑜.经会阴前列腺12+x针穿刺活检中不同穿刺部位前列腺癌检出率比较[J].医学信息,2021,34(22):88-90.[doi:10.3969/j.issn.1006-1959.2021.22.026]
　BEI Ming-long,MIAO Yu.Comparison of the Detection Rate of Prostate Cancer in Different Puncture Sites in Perineal Prostate 12+x Needle Puncture[J].Medical Information,2021,34(22):88-90.[doi:10.3969/j.issn.1006-1959.2021.22.026]
点击复制

经会阴前列腺12+x针穿刺活检中不同穿刺部位前列腺癌检出率比较()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年22期
页码:
88-90
栏目:
论著
出版日期:
2021-11-15

文章信息/Info

Title:
Comparison of the Detection Rate of Prostate Cancer in Different Puncture Sites in Perineal Prostate 12+x Needle Puncture
文章编号:
1006-1959（2021）22-0088-03
作者:
贝明龙; 缪 瑜
（常熟市第二人民医院泌尿外科，江苏 常熟 215500）
Author(s):
BEI Ming-long; MIAO Yu
(Department of Urology,Changshu No.2 People’s Hospital,Changshu 215500,Jiangsu,China)
关键词:
前列腺癌; 会阴前列腺12+x针穿刺; 前列腺特异性抗原
Keywords:
Prostate cancer; Perineal prostate 12+x needle puncture; Prostate specific antigen
分类号:
R737.25
DOI:
10.3969/j.issn.1006-1959.2021.22.026
文献标志码:
A
摘要:
目的 研究经会阴前列腺12+x针穿刺活检中不同穿刺部位前列腺癌的检出率。方法 选取2019年1月-2020年10月我院收治的78例疑似前列腺癌患者为研究对象，患者均在超声引导下经会阴进行前列腺12+x针穿刺活检，观察经会阴前列腺12+x针穿刺活检阳性率，并比较良恶性前列腺肿瘤前列腺特异性抗原（PSA）水平和体积及不同PSA水平和不同体积下12+x针不同穿刺部位前列腺癌检出率。结果 78例疑似前列腺癌患者中，经病理学检查证实确诊35例前列腺癌，12+x针穿刺活检阳性率为44.87%（35/78）；前列腺癌患者PSA水平高于良性前列腺增生，体积小于良性前列腺增生，差异有统计学意义（P＜0.05）。不同PSA水平下不同位置前列腺癌检出率比较，差异有统计学意义（P＜0.05），且随PSA水平降低，检出率也随之降低；相同PSA水平下，不同位置穿刺部位前列腺癌阳性检出率比较，差异无统计学意义（P＞0.05）。不同体积下不同位置前列腺癌检出率比较，差异有统计学意义（P＜0.05），且随体积的减小，检出率随之升高；相同体积下，不同位置穿刺部位前列腺癌阳性检出率比较，差异无统计学意义（P＞0.05）。结论 经会阴前列腺12+x针穿刺活检是诊断前列腺癌有效可行的方法，相同血清PSA水平、体积下不同穿刺部位阳性检出率基本一致，而不同体积、PSA水平阳性检出率存在差异。因此，在前列腺穿刺活检前应充分考虑体积、PSA水平，以获得更满意的穿刺和诊断结果。
Abstract:
Objective To study the detection rate of prostate cancer at different puncture sites in perineal prostate 12+x needle puncture.Methods A total of 78 patients with suspected prostate cancer admitted to our hospital from January 2019 to October 2020 were selected as the research objects. All patients underwent ultrasound-guided Perineal prostate 12+x needle puncture of the prostate. The positive rate of transperineal 12+x needle biopsy of the prostate was observed, and the prostate specific antigen (PSA) level and volume of benign and malignant prostate tumors and the detection rate of prostate cancer at different puncture sites of 12+x needles under different PSA levels and different volumes were compared.Results Among 78 patients with suspected prostate cancer, 35 cases were confirmed by pathological examination, and the positive rate of 12+x needle biopsy was 44.87% (35/78). The PSA level of prostate cancer patients was higher than that of benign prostatic hyperplasia, and the volume was smaller than that of benign prostatic hyperplasia, the difference was statistically significant (P<0.05). The detection rates of prostate cancer at different locations under different PSA levels were statistically significant (P<0.05), and the detection rate decreased with the decrease of PSA level; under the same PSA level, there was no significant difference in the positive detection rate of prostate cancer at different puncture sites (P>0.05). There was significant difference in the detection rate of prostate cancer at different locations under different volumes (P<0.05), and the detection rate increased with the decrease of volume; under the same volume, there was no significant difference in the positive detection rate of prostate cancer at different puncture sites (P>0.05).Conclusion 12+x transperineal prostate needle biopsy is an effective and feasible method for the diagnosis of prostate cancer. The positive detection rates at different puncture sites are basically the same at the same serum PSA level and volume, while the positive detection rates at different volumes and PSA levels are different. Therefore, volume and PSA level should be fully considered before prostate biopsy to obtain more satisfactory puncture and diagnosis results.

参考文献/References:

[1]Odorizzi K,Tafuri A,Gozzo A,et al.Predictors of prostatic chronic inflammation and prostate cancer risk at baseline random biopsies: Results from a large population of caucasian patients[J].European Urology Open Science,2020(20):S60-S61.[2]郭飞,刘久敏,蒲小勇,等.超声引导下12+x针前列腺穿刺活检单中心407例临床分析[J].临床泌尿外科杂志,2021,36(1):12-17.[3]徐郑,张乐乐,俞飞,等.68Ga-PSMA PET/CT靶向穿刺对血清PSA<20.0 ng/ml患者有临床意义前列腺癌的诊断研究[J].中华泌尿外科杂志,2020,41(10):752-756.[4]陈创华,方建华,徐陈柯,等.多普勒超声引导前列腺靶向穿刺活检在前列腺癌诊断中的应用价值[J].中国慢性病预防与控制,2020,28(10):778-780.[5]周俊红,赵玉保,安瑞.超声引导下经直肠前列腺穿刺活检结合血清前列腺特异性抗原诊断前列腺癌中价值分析[J].实用医技杂志,2020,27(10):1379-1380.[6]李培,徐光,王帅,等.经会阴前列腺8针穿刺活检中不同穿刺部位前列腺癌检出率的比较[J].肿瘤影像学,2020,29(3):294-298.[7]杨进,喻备,王云汉,曹洪豪.联合应用MRI图像重建及经直肠超声引导前列腺12+x针穿刺活检术[J].四川解剖学杂志,2016,24(2):21-23,26.[8]郭小鹏,成俊,王鹏.血清前列腺特异抗原、直肠指检联合磁共振波谱成像对前列腺癌的诊断价值[J].中国实验诊断学,2016,20(3):381-384.[9]王辉,邰胜,周骏,等.经直肠超声引导下12+X前列腺穿刺法诊断前列腺癌的优势性分析[J].中华泌尿外科杂志,2016,37(8):611-615.[10]Bae JH,Kim SH.Transrectal ultrasound-guided prostate biopsy versus combined magnetic resonance imaging-ultrasound fusion and systematic biopsy for prostate cancer detection in routine clinical practice[J].Ultrasonography,2020,39(2):137-143.[11]杨凌博,王鹏森,李法平,等.超声引导下经直肠前列腺穿刺活检6针法、10针法和12针法诊断前列腺癌的比较[J].中国老年学杂志,2015,35(6):1578-1580.[12]Al-Yasiri AY,White NE,Katti KV,et al.Estimation of tumor and local tissue dose in gold nanoparticles radiotherapy for prostate cancer[J].Rep Pract Oncol Radiother,2019,24(3):288-293.[13]郭刚,许勇,王岩,等.直肠超声引导经会阴模版12+X针前列腺穿刺活检术临床研究[J].微创泌尿外科杂志,2015,3(5):263-267.[14]Tafuri A,Sebben M,Novella G,et al.Prostatic chronic inflammation and prostate cancer risk at baseline random biopsy: Analysis of predictors[J].Arab J Urol,2020,18(3):148-154.[15]粘迪,吴桐,何健,等.经直肠超声引导下穿刺活检术结合血清前列腺特异抗原水平在老年前列腺癌中的临床价值[J].当代医学,2021,27(5):16-19.

相似文献/References:

[1]袁长翮.超声引导下经直肠前列腺穿刺诊断前列腺癌的价值研究[J].医学信息,2018,31(04):156.[doi:10.3969/j.issn.1006-1959.2018.04.058]
　YUAN Chang-he.The Value of Ultrasound Guided Transrectal Prostate Puncture in the Diagnosis of Prostate Cancer[J].Medical Information,2018,31(22):156.[doi:10.3969/j.issn.1006-1959.2018.04.058]
[2]廖 祺,黄 一,徐 雪.前列腺癌骨转移的疼痛管理[J].医学信息,2018,31(06):51.[doi:10.3969/j.issn.1006-1959.2018.06.017]
　LIAO Qi,HUANG Yi,XU Xue.Pain Management of Bone Metastasis in Prostate Cancer[J].Medical Information,2018,31(22):51.[doi:10.3969/j.issn.1006-1959.2018.06.017]
[3]胡春燕,吴天天,王 殊,等.前列腺癌患者自我感受负担及其影响因素研究[J].医学信息,2018,31(13):173.[doi:10.3969/j.issn.1006-1959.2018.13.054]
　HU Chun-yan,WU Tian-tian,WANG Shu,et al.Study on Self-perceived Burden and its Influencing Factors in Patients with Prostate Cancer[J].Medical Information,2018,31(22):173.[doi:10.3969/j.issn.1006-1959.2018.13.054]
[4]曹志彬,王元天,杨伟忠,等.前列腺健康指数在前列腺癌早期诊断中的价值[J].医学信息,2018,31(23):29.[doi:10.3969/j.issn.1006-1959.2018.23.009]
　CAO Zhi-bin,WANG Yuan-tian,YANG Wei-zhong,et al.The Value of Prostate Health Index in Early Diagnosis of Prostate Cancer[J].Medical Information,2018,31(22):29.[doi:10.3969/j.issn.1006-1959.2018.23.009]
[5]张 莹,谢 静.前列腺癌预后标志的研究[J].医学信息,2019,32(09):7.[doi:10.3969/j.issn.1006-1959.2019.09.003]
　ZHANG Ying,XIE Jing.Prognostic Markers of Prostate Cancer[J].Medical Information,2019,32(22):7.[doi:10.3969/j.issn.1006-1959.2019.09.003]
[6]袁也晴,张学齐,汪青蓉,等.KIF14在前列腺癌细胞中的表达及作用[J].医学信息,2019,32(09):68.[doi:10.3969/j.issn.1006-1959.2019.09.022]
　YUAN Ye-qing,ZHANG Xue-qi,WANG Qing-rong,et al.Expression and Role of KIF14 in Prostate Cancer Cells[J].Medical Information,2019,32(22):68.[doi:10.3969/j.issn.1006-1959.2019.09.022]
[7]王 乾,孙 宾,李殷南,等.尿液中肌氨酸、PCA3mRNA在前列腺癌 早期诊断中的应用[J].医学信息,2019,32(14):175.[doi:10.3969/j.issn.1006-1959.2019.14.059]
　WANG Qian,SUN Bin,LI Yin-nan,et al.Application of Urinary Sarcosine and PCA3mRNA in Early Diagnosis of Prostate Cancer[J].Medical Information,2019,32(22):175.[doi:10.3969/j.issn.1006-1959.2019.14.059]
[8]李熹阳,谷明宇,华 琳.影响前列腺癌风险的关键基因识别[J].医学信息,2020,33(02):80.[doi:10.3969/j.issn.1006-1959.2020.02.022]
　LI Xi-yang,GU Ming-yu,HUA Lin.Identification of Key Genes Affecting Prostate Cancer Risk[J].Medical Information,2020,33(22):80.[doi:10.3969/j.issn.1006-1959.2020.02.022]
[9]黄 鹏,廖鑫鑫,陆文宝,等.临床评分系统预测前列腺癌根治术后生化复发的研究[J].医学信息,2020,33(08):76.[doi:10.3969/j.issn.1006-1959.2020.08.025]
　HUANG Peng,LIAO Xin-xin,LU Wen-bao,et al.Clinical Scoring System Predicts the Value of Biochemical Recurrence after Radical Prostatectomy[J].Medical Information,2020,33(22):76.[doi:10.3969/j.issn.1006-1959.2020.08.025]
[10]陈彦君,刘建萍,龚志勇.预测前列腺癌根治术后生化复发的研究[J].医学信息,2021,34(05):49.[doi:10.3969/j.issn.1006-1959.2021.05.015]
　CHEN Yan-jun,LIU Jian-ping,GONG Zhi-yong.Study on the Prediction of Biochemical Recurrence After Radical Prostatectomy[J].Medical Information,2021,34(22):49.[doi:10.3969/j.issn.1006-1959.2021.05.015]

更新日期/Last Update: 1900-01-01